Vina Churdboonchart
Corporate Officer/Principal at Mahidol University
Vina Churdboonchart active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Mahidol University | Corporate Officer/Principal | 2010-02-24 | - |
Career history of Vina Churdboonchart
Former positions of Vina Churdboonchart
| Companies | Position | Start | End |
|---|---|---|---|
Trinity Medical Group, Inc.
 Trinity Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Trinity Medical Group, Inc. markets HIV-Immunogen also known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus. REMUNE is an immune-based therapy consisting of whole inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology. The company was founded on September 28, 1998 and is headquartered in Las Vegas, NV. | Head-Fixed Income Invts | 2010-02-24 | 2010-02-24 |
| Founder | 2010-02-24 | 2010-02-24 | |
| President | 2010-02-24 | - |
Statistics
International
| United States | 2 |
| Thailand | 2 |
Operational
| Head-Fixed Income Invts | 1 |
| Founder | 1 |
| President | 1 |
Sectoral
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Trinity Medical Group, Inc.
Trinity Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Trinity Medical Group, Inc. markets HIV-Immunogen also known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus. REMUNE is an immune-based therapy consisting of whole inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology. The company was founded on September 28, 1998 and is headquartered in Las Vegas, NV. | Commercial Services |
- Stock Market
- Insiders
- Vina Churdboonchart
- Experience
